UBS Group’s InspireMD, Inc. Warrants NSPRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-19,296
| Closed | -$4K | – | 10804 |
|
|
2021
Q2 | $4K | Buy |
19,296
+17,109
| +782% | +$2.01K | ﹤0.01% | 8765 |
|
|
2021
Q1 | $0 | Sell |
2,187
-47,906
| -96% | -$6.77K | ﹤0.01% | 9828 |
|
|
2020
Q4 | $2K | Sell |
50,093
-2,774
| -5% | -$76 | ﹤0.01% | 8177 |
|
|
2020
Q3 | $1K | Sell |
52,867
-21,987
| -29% | -$321 | ﹤0.01% | 7901 |
|
|
2020
Q2 | $1K | Sell |
74,854
-15,032
| -17% | -$143 | ﹤0.01% | 7867 |
|
|
2020
Q1 | $0 | Buy |
89,886
+37,381
| +71% | +$280 | ﹤0.01% | 8656 |
|
|
2019
Q4 | $0 | Hold |
52,505
| – | – | ﹤0.01% | 8588 |
|
|
2019
Q3 | $0 | Sell |
52,505
-6,655
| -11% | -$49 | ﹤0.01% | 8422 |
|
|
2019
Q2 | $1K | Buy |
59,160
+300
| +0.5% | +$2 | ﹤0.01% | 7775 |
|
|
2019
Q1 | $1K | Buy |
58,860
+1,819
| +3% | +$12 | ﹤0.01% | 7608 |
|
|
2018
Q4 | $0 | Buy |
57,041
+33,600
| +143% | +$71 | ﹤0.01% | 8461 |
|
|
2018
Q3 | $0 | Buy |
+23,441
| New | +$159 | ﹤0.01% | 8414 |
|
|
2018
Q1 | – | Sell |
-10,099
| Closed | – | – | 8329 |
|
|
2017
Q4 | $0 | Buy |
10,099
+1,275
| +14% | +$41 | ﹤0.01% | 8222 |
|
|
2017
Q3 | $0 | Buy |
8,824
+5,700
| +182% | +$476 | ﹤0.01% | 8126 |
|
|
2017
Q2 | $0 | Buy |
3,124
+2,640
| +545% | +$300 | ﹤0.01% | 8132 |
|
|
2017
Q1 | $0 | Buy |
+484
| New | +$203 | ﹤0.01% | 8137 |
|
UBS Group's NSPRW Position: Q3 2021 in Review
UBS Group sold out of InspireMD, Inc. Warrants (NSPRW) in Q3 2021, closing a stake of 19,296 shares — an estimated $4K sold.
UBS Group first reported a position in NSPRW in Q1 2017 and held it in 16 quarters. The position peaked at $4K in Q2 2021. 0 funds tracked by Wall St. Rank hold NSPRW as of Q3 2021.
- UBS Group reported no remaining InspireMD, Inc. Warrants position as of Q3 2021 after selling out during the quarter.
- UBS Group sold 19,296 InspireMD, Inc. Warrants shares in Q3 2021, an estimated $4K.
- UBS Group first reported a position in InspireMD, Inc. Warrants in Q1 2017 and held it in 16 quarters.
- UBS Group's InspireMD, Inc. Warrants position peaked at $4K in Q2 2021.
- 0 funds tracked by Wall St. Rank held InspireMD, Inc. Warrants as of Q3 2021.
Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.